Colorectal cancer vaccine - Onyvax
Alternative Names: Onyvax CRLatest Information Update: 02 Oct 2021
At a glance
- Originator Onyvax
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 26 May 2008 Discontinued - Phase-I/II for Colorectal cancer in United Kingdom (unspecified route)
- 05 Mar 2004 This compound is still in active development
- 02 May 2000 Phase-I/II clinical trials for Colorectal cancer in United Kingdom (Unknown route)